Drug Trial Radar · NCT04041609
LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)
Last checked: Nov 19, 2026Latest source record: Jul 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
71
Actual
Start
May 9, 2019
Primary completion
Mar 25, 2020
Study completion Feb 4, 2021
Sponsor
- Lead sponsor
- Lyra TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Aug 1, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase II, Randomized, Blinded, Sham Procedure-Controlled, Parallel-Group Trial to Evaluate the Efficacy, Safety and Tolerability of LYR-210 in Adult Subjects with Chronic Sinusitis.
Conditions
- Chronic Sinusitis
- Chronic Rhinosinusitis (Diagnosis)
Interventions
LYR-210Drug
A single administration of LYR-210 depot
Sham comparatorOther
Sham comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline (CFBL) in Chronic Sinusitis Symptom Scores at Week 4Time frame: Week 4
Locations
22 sites in 5 countries. Site status is shown where the registry gives one.
Royal Brisbane and Woman's Hospital
Brisbane, Australia
Monash Health
Clayton, Australia
The ENT Centre
Hornsby, Australia
Westmead Hospital
Westmead, Australia
University Hospital for Otorhinolaryngology, Medical University of Graz
Vienna, Austria
Fakultni Nemocnice Brno OR
Brno, Czechia
St Anne's Faculty Hospital
Brno, Czechia
Fakultní nemocnice Plzeň
Pilsen, Czech Republic, Czechia
Fakultni Nemocnice Hradec Kralove Klinika otorinolaryngologie a chirurgie hlavy a krku
Hradec Králové, Prague, Czechia
Southern Clinical Trials Waitemata
Auckland, New Zealand
Southern Clinical Trials Ltd
Christchurch, New Zealand
Clinical Trials New Zealand
Hamilton, New Zealand
Middlemore Clinical Trials
Papatoetoe, New Zealand
P3 Research Tauranga
Tauranga, New Zealand
P3 Research Wellington
Wellington, New Zealand
Wellington Hospital
Wellington, New Zealand
Provita Sp. z o.o. Centrum Medyczne Angelius Provita
Katowice, Poland
Centrum Medyczne All-Med
Krakow, Poland
Centrum Medyczne Plejady
Krakow, Poland
Centrum Medyczne PROMED
Krakow, Poland
Centrum Zdrowia MDM
Warsaw, Poland
Vistamed Sp. z o.o.
Wroclaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.